Earnings Feed
Start Free
Home/Filings/4/0001209191-15-048533
4//SEC Filing

Adamas Pharmaceuticals Inc 4

Accession 0001209191-15-048533

CIK 0001328143operating
View on SEC.govCompany Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 8:09 PM ET

Size

24.3 KB

Accession

0001209191-15-048533

Insider Transaction Report

Form 4
Period: 2015-05-28
Adamas Pharmaceuticals IncADMS
Ninth MDV Partners, L.L.C.
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146
MDV ENF VII (A), L.P.
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150
MDV VII Leaders' Fund, L.P.
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661
MDV IX LP
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686
Seventh MDV Partners, L.L.C.
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661
MDV ENF VII (B), L.P.
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686
FEIBER JONATHAN D
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146
SCHOENDORF NANCY J
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146
MDV VII LP
10% Owner
Transactions
  • Sale

    Common Stock

    2015-05-28$18.02/sh−7,483$134,821→ 453,401 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
  • Sale

    Common Stock

    2015-05-29$18.02/sh−112,073$2,019,555→ 341,328 total(indirect: MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF)
Holdings

  • Common Stock

    (indirect: MDV VII, L.P.)
    265,150

  • Common Stock

    (indirect: MDV ENF VII (B), L.P.)
    3,146

  • Common Stock

    (indirect: MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP)
    3,772,686

  • Common Stock

    (indirect: MDV VII Leaders' Fund, L.P.)
    25,661

  • Common Stock

    (indirect: MDV ENF VII (A), L.P.)
    6,043
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by MDV IX on December 15, 2014.
  • [F2]Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $18.00 and $18.08 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Ninth MDV Partners, L.L.C. is the general partner of MDV IX, L.P., as nominee for MDV IX, L.P. and MDV ENF IX, L.P. (collectively, "MDV IX"). William Ericson ("Ericson") and Jonathan Feiber ("Feiber") are Managing Members of Ninth MDV Partners, L.L.C. Ericson and Feiber may be deemed to share voting and dispositive power over the shares held by MDV IX. Each Reporting Person disclaims beneficial ownership of the shares held by MDV IX except to the extent of any pecuniary interest therein. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.
  • [F4]Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $18.00 and $18.110 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F5]Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV ENF VII(A), L.P., MDV ENF VII(B), L.P., and MDV VII Leaders' Fund, L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P., and (v) MDV VII Leaders' Fund, L.P. (collectively, "MDV VII"). Feiber and Nancy Schoendorf ("Schoendorf") are Managing Members of Seventh MDV Partners, L.L.C. Feiber and Schoendorf may be deemed to share voting and dispositive power over the shares held by MDV VII. Each Reporting Person disclaims beneficial ownership of the shares held by MDV VII except to the extent of any pecuniary interest therein. Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with MDV VII. Ericson is a director of the Issuer and, accordingly, files separate Section 16 reports.

Documents

1 file

Issuer

Adamas Pharmaceuticals Inc

CIK 0001328143

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001328143

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 8:09 PM ET
Size
24.3 KB
View on SEC.gov